A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients

Lignende værker

• Relationship between pharmacokinetic profile of subcutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia
  af: Michela Montagna, et al.
  Udgivet: (2011-06-01)
• Characteristics and stage of the underlying diseases could determine the risk of opportunistic infections in patients receiving alemtuzumab
  af: A. Nosari, et al.
  Udgivet: (2008-02-01)
• Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia
  af: Miguel Ruiz, et al.
  Udgivet: (2024-11-01)
• THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
  af: Francesca Ricci, et al.
  Udgivet: (2011-07-01)
• THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
  af: Alessandra Tedeschi, et al.
  Udgivet: (2011-01-01)